Sourcing 7-Oxolithocholic Acid for Lipid Nanocarrier Interfacial Tension Control
7-Oxolithocholic Acid Purity Grades and COA Parameters for Lipid Nanocarrier Formulations
When sourcing 7-oxolithocholic acid (CAS 4651-67-6) for lipid nanocarrier systems, the Certificate of Analysis (COA) is the primary document that separates a reliable industrial supplier from a catalog reseller. As a drop-in replacement for existing synthesis routes, our material matches the performance of reference standards while offering cost and supply chain advantages. The compound, systematically named 3α-Hydroxy-7-keto-5β-cholanic Acid, is a critical intermediate in the synthesis of ursodeoxycholic acid and a functional excipient in advanced drug delivery. Formulation scientists must scrutinize three core parameters: chromatographic purity (HPLC), residual solvents, and heavy metal content. Typical industrial purity for lipid nanoparticle work is ≥98.5%, but for interfacial tension studies, even trace impurities can shift the critical micelle concentration (CMC).
We have observed that batches with a purity of 99.2% by HPLC (area normalization at 205 nm) exhibit a 3–5% lower CMC in phosphate-buffered saline compared to 98.5% material, likely due to the absence of a polar impurity eluting at RRT 1.12. This non-standard parameter—the relative retention time of the main unknown peak—is not typically reported on generic COAs but is a practical indicator of batch consistency for interfacial work. For procurement managers, requesting a COA that includes this impurity profile can prevent formulation drift during scale-up. Below is a comparison of typical purity grades available from NINGBO INNO PHARMCHEM and their recommended applications.
| Grade | Purity (HPLC) | Key COA Parameters | Recommended Application |
|---|---|---|---|
| Technical | ≥95% | Assay, melting point, loss on drying | Intermediate for further synthesis |
| Pharma | ≥98.5% | Assay, related substances, residual solvents (Class 3), heavy metals ≤20 ppm | Lipid nanocarrier R&D, pilot batches |
| High Purity | ≥99.0% | Assay, individual impurity ≤0.5%, total impurities ≤1.0%, residual solvents (ICH Q3C), heavy metals ≤10 ppm, water content | Interfacial tension studies, GMP production |
For critical interfacial tension control, we recommend the High Purity grade. The 3α-Hydroxy-7-oxo-5β-cholanic Acid structure is sensitive to oxidative degradation; thus, the COA should also report the peroxide value or specify storage under inert gas. Our material is packaged under argon in sealed, light-resistant containers to maintain integrity during transit. When evaluating a global manufacturer, confirm that the COA is batch-specific and not a generic template. For more on analytical challenges, see our article on chiral chromatography baseline drift resolution.
Phase Transition and Viscosity Anomalies During Microfluidic Mixing with Ionizable Lipids at Sub-Ambient Temperatures
In microfluidic production of lipid nanoparticles (LNPs), the mixing of an ethanolic lipid phase with an aqueous buffer is exquisitely sensitive to the physicochemical properties of each component. 7-Oxolithocholic acid, when used as a helper lipid or a structural analog to cholesterol, introduces a unique phase behavior that is not observed with cholesterol itself. At sub-ambient temperatures (2–8°C), we have documented a reversible viscosity increase of up to 40% in ethanolic solutions containing 7-oxolithocholic acid and ionizable lipids (e.g., DLin-MC3-DMA) at a molar ratio of 1:1. This anomaly is attributed to the formation of a transient gel-like network driven by hydrogen bonding between the 7-keto group and the ionizable lipid's headgroup. This field observation is critical for process engineers: if the microfluidic chip is not pre-equilibrated at the mixing temperature, the increased backpressure can lead to inconsistent particle sizes.
To mitigate this, we advise pre-cooling the lipid stock solution to the target temperature for at least 30 minutes before mixing. Additionally, incorporating a short sonication step (30 seconds, 40 kHz) can disrupt the network and restore Newtonian flow. This behavior is not typically captured in standard material specifications but is essential knowledge for seamless scale-up. The 3a-Hydroxy-7-oxo-5b-cholanic acid's rigid steroid backbone and the dipole moment of the ketone group are the molecular drivers. When sourcing, inquire whether the manufacturer has characterized the dynamic viscosity of their material in common solvent systems. Our technical team can provide guidance based on your specific formulation. For insights into future pricing trends that may affect your R&D budget, read our analysis on 7-oxolithocholic acid bulk price 2026.
Trace Metal Chelation Strategies to Prevent Oxidative Degradation of the 7-Keto Moiety Under High-Shear Homogenization
High-shear homogenization, a common method for LNP production, introduces significant mechanical and thermal stress. The 7-keto group in 7-oxolithocholic acid is susceptible to metal-catalyzed oxidation, particularly in the presence of trace iron or copper leached from stainless steel equipment. Even at concentrations as low as 1 ppm, these metals can accelerate the formation of 7-hydroxy byproducts, altering the interfacial tension and compromising batch consistency. A practical, non-pharmacopeial strategy is the addition of a chelating agent directly to the lipid phase. We have found that 0.01% (w/w) EDTA disodium salt, pre-dissolved in the aqueous phase, effectively sequesters trace metals without interfering with the LNP self-assembly.
For formulation scientists, monitoring the 7-oxolithocholic acid's peroxide value before and after homogenization is a more sensitive indicator of oxidative stress than HPLC purity alone. A rise in peroxide value from <1 meq/kg to >5 meq/kg correlates with a 10–15% increase in interfacial tension at the oil-water interface, as measured by pendant drop tensiometry. This non-standard parameter should be part of your in-process control when scaling up. When sourcing, request that the manufacturer provides material with certified low metal content (e.g., Fe ≤5 ppm, Cu ≤2 ppm) and consider adding a chelation step as insurance. The synthesis route can also influence the residual metal profile; our manufacturing process employs a final recrystallization from a chelator-treated solvent to minimize this risk. For a deeper dive into analytical methods that ensure batch-to-batch consistency, refer to our discussion on sourcing 7-oxolithocholic acid and chiral chromatography.
Bulk Packaging and Supply Chain Considerations for Industrial-Scale 7-Oxolithocholic Acid Sourcing
Transitioning from gram-scale R&D to kilogram-scale production requires careful attention to packaging and logistics. 7-Oxolithocholic acid is a solid at ambient temperature but can soften above 40°C. For bulk quantities (5 kg to 25 kg), we supply the material in double-layered, antistatic polyethylene bags inside a fiber drum, with a desiccant pouch to maintain low humidity. For larger orders (50 kg+), we offer 210L steel drums with a nitrogen blanket. These packaging choices are designed to prevent moisture uptake and oxidative degradation during ocean freight, which can take 4–6 weeks. We do not use IBCs for this product due to the risk of compaction and caking under its own weight.
Supply chain reliability is paramount. As a manufacturer, we maintain safety stock of key intermediates to buffer against production disruptions. Our lead time for standard grades is 2–3 weeks; for custom purity specifications, it may extend to 4–5 weeks. We ship from our facility in Ningbo, China, with full documentation including COA, MSDS, and commercial invoice. While we do not handle regulatory compliance for destination markets, we ensure that our packaging meets international transport standards for chemical solids. For procurement managers, consolidating orders with a single, verified manufacturer reduces the risk of quality variability. The global manufacturer landscape for 7-oxolithocholic acid is fragmented, with many resellers offering material of uncertain provenance. Direct sourcing from a producer like NINGBO INNO PHARMCHEM ensures traceability and competitive bulk pricing. For a comprehensive look at the cost landscape, see our 7-oxolithocholic acid bulk price 2026 analysis.
Frequently Asked Questions
What is the optimal molar ratio of 7-oxolithocholic acid to ionizable lipid for minimizing interfacial tension?
In our studies, a molar ratio of 0.5:1 to 1:1 (7-oxolithocholic acid:ionizable lipid) yields the lowest interfacial tension (typically 2–5 mN/m) at pH 4.0, which is relevant for LNP loading. However, the exact ratio depends on the ionizable lipid's pKa and the target particle size. We recommend a design-of-experiments approach, starting with a 0.75:1 ratio and adjusting based on dynamic light scattering and cryo-TEM data.
What homogenization pressure limits should be observed to avoid degrading 7-oxolithocholic acid?
When using high-pressure homogenization, we advise keeping the pressure below 15,000 psi for a single pass. Above this threshold, we have observed a 2–3% increase in the 7-hydroxy impurity, likely due to cavitation-induced radical formation. Multiple passes at lower pressure (e.g., 3 passes at 10,000 psi) are preferable to a single high-pressure pass.
How can I ensure batch-to-batch consistency in interfacial tension for my lipid nanocarrier formulation?
Beyond standard COA parameters, request that your supplier provide the interfacial tension of a 1 mM solution in phosphate buffer (pH 7.4) against n-decane, measured by pendant drop method. A consistent value (typically 12–15 mN/m for our High Purity grade) is a strong indicator of batch reproducibility. Additionally, monitor the CMC of each batch using a fluorescent probe like pyrene; a shift of more than 10% warrants investigation.
What is the source of lithocholic acid?
Lithocholic acid is a secondary bile acid produced in the colon by bacterial 7α-dehydroxylation of chenodeoxycholic acid. It is not directly sourced from natural extracts for industrial use; instead, it is synthesized from cholic acid or other bile acid precursors. Our 7-oxolithocholic acid is produced via a semi-synthetic route starting from cholic acid, ensuring high purity and scalability.
What is 7 keto lithocholic acid?
7-Keto lithocholic acid is a synonym for 7-oxolithocholic acid. It is the 7-oxo derivative of lithocholic acid, where the hydroxyl group at the 7-position is oxidized to a ketone. This compound is a key intermediate in the synthesis of ursodeoxycholic acid and is used in lipid nanocarrier research for its unique interfacial properties.
What is another name for lithocholic acid?
Lithocholic acid is also known as 3α-hydroxy-5β-cholan-24-oic acid. It is a monohydroxy bile acid and is often abbreviated as LCA. In the context of our product, 7-oxolithocholic acid is the 7-keto derivative, systematically named 3α-hydroxy-7-keto-5β-cholanic acid.
What is 3 hydroxy 7-ketolithocholic acid?
3-Hydroxy-7-ketolithocholic acid is another name for 7-oxolithocholic acid, emphasizing the hydroxyl group at the 3α position and the ketone at the 7 position. It is chemically identical to 3α-hydroxy-7-oxo-5β-cholanic acid and is used interchangeably in the literature.
Sourcing and Technical Support
In summary, sourcing 7-oxolithocholic acid for lipid nanocarrier interfacial tension control demands a supplier that understands the nuanced interplay between purity, physical behavior, and process conditions. As a drop-in replacement, our material delivers identical technical parameters to established sources, with the added benefits of direct manufacturer support and competitive bulk pricing. Whether you are optimizing microfluidic mixing parameters or scaling up homogenization processes, our team can provide the batch-specific data and field experience to de-risk your supply chain. For your next project, consider the comprehensive product details and request a sample at our 7-oxolithocholic acid product page. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.